title: Application of nanosized Fe3O4 in anticancer drug carriers with target-orientation and sustained-release properties.
abstract: The purpose of this study was to prepare human serum albumin (HSA) microspheres with Fe(3)O(4) magnetic nanoparticles for tumor target therapy. Fe(3)O(4) was obtained by liquid-phase coprecipitation; HSA-coated magnetic particles were attained by solidification at high temperature. The result was that nanosized Fe(3)O(4) is a cubic crystal by XRD and the average size is 18.7 nm; the average size of HSA-coated magnetic particles is 341 nm. Fe(3)O(4) magnetic nanoparticles coated with HSA can be used for targeted-drug carriers with target-orientation and sustained-release properties.
authors.affiliation: College of Material Science and Technology, Nanjing, 210009, People's Republic of China.
authors.forename: Ben-Lan
authors.initials: BL
authors.lastname: Lin
authors.forename: Xiao-Dong
authors.initials: XD
authors.lastname: Shen
authors.forename: Sheng
authors.initials: S
authors.lastname: Cui
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000737:chemistry; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000737:chemistry*; D004337:Drug Carriers / Q000008:administration & dosage / Q000737:chemistry*; D005296:Ferrous Compounds / Q000737:chemistry*; D008280:Magnetics / Q000627:therapeutic use*; D008422:Materials Testing; D049329:Nanostructures / Q000737:chemistry* / Q000648:ultrastructure; D010316:Particle Size
chemical_list: D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D005296:Ferrous Compounds; C034236:ferrous oxide